Determining the best premedication regimen to prevent rabbit anti-human thymocyte globulin infusion-associated reactions: A retrospective study comparing two hematopoietic stem cell transplant centers
ATG3 given the day after HSCT appears to play a key role in reducing the incidence and severity of IAR. Infusion over six hours at a fixed rate was safe. Frequent, regular, and extended doses of acetaminophen and antihistamines beyond ATG infusion appear useful. Increasing CS doses led to IAR reduction, but this correlated with an increased infection rate.
Authors
- Guy Cantin
- Marie-Hélène Leblanc
- Keven Vachon
- Marc-Antoine Tardif
- Christopher Lemieux (ORCID: https://orcid.org/0000-0002-0281-5866)
- Geneviève Gallagher
- Étienne Paillé
Institutions
- Université du Québec à Rimouski (CA)
- Cégep de Rimouski (CA)
- Centre hospitalier de l'Université Laval (CA)
- Université Laval (CA)
Publication Details
- Journal
- Transplant Immunology
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1016/j.trim.2025.102178
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fondation CHU de Québec